PRODUCTS
| Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
|---|---|---|---|---|---|---|---|
| Budesonide Inhalation Suspension | 0.5 mg/2 mL |
 |
30 SD Ampules |
68180-984-30 |
Pulmicort Respules Inhalation Suspension |
AN |
Anti-inflammatory |
| Cefixime Capsules | 400 mg |
 |
1 x 10 |
68180-423-11 |
Suprax® |
AB |
Antibacterial |
| Clobazam Tablets | 10 mg |
 |
100 |
68180-157-01 |
Onfi® |
AB |
Sedative-Hypnotic |
| Moxifloxacin Ophthalmic Solution USP | 0.5% |
 |
3mL (in a 5mL Bottle) |
68180-422-01 |
Vigamox® |
AT2 |
Antibiotic |
| Orphenadrine Citrate ER Tablets | 100mg |
 |
100 |
43386-480-24 |
Norflex® |
AB |
Centrally Acting |
| Oseltamivir Phosphate Capsules USP | 30 mg |
|
10 |
68180-675-11 |
Tamiflu® |
AB |
Antivirals |
| Albuterol Sulfate Inhalation Aerosol | 90 mcg per actuation |
 |
8.5g |
68180-963-01 |
PROAIR® HFA |
AB2 |
Bronchodilator |
| Leflunomide Tablets USP | 10 mg |
 |
30 |
70748-129-06 |
Arava® |
AB |
Immune Suppressant |
| Divalproex Sodium Extended-Release Tablets USP | 250mg |
|
100 |
68180-260-01 |
Depakote® ER |
AB |
Anti-Convulsant |
| Lapatinib Tablets | 250 mg |
|
150 |
68180-0801-36 |
Tykerb® |
AB |
Antineoplastic Agent |
| Posaconazole Delayed-Release Tablets | 100mg |
 |
60 |
70748-0258-07 |
Noxafil® |
AB |
Antifungal |
| Penicillamine Tablets USP | 250 mg |
|
100 |
70748-0153-01 |
Depen® |
AB |
Antirheumatic |
| Arformoterol Tartrate Inhalation Solution | 15mcg/2mL |
|
30 UD Vials |
70748-175-30 |
Brovana® |
NA |
Long-acting beta agonists (LABAs) |
| Meloxicam Capsules | 5mg |
|
30 |
68180-188-06 |
Vivlodex® |
AB |
analgesic |
| Tiotropium Bromide Inhalation Powder Capsules | 18mcg / capsules |
 |
30 |
68180-964-12 |
Spiriva® HandiHaler® |
AB |
Anticholinergics |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.
